1. Attitudes of California school personnel on potential COVID-19 vaccine mandates and state law SB277 to remove nonmedical vaccine exemptions.
- Author
-
Dudley MZ, Zapf AJ, Delamater P, Proveaux TM, Schuh HB, Buttenheim AM, Schwartz JL, Klein NP, Goddard K, Patel KM, Omer SB, and Salmon DA
- Abstract
California passed Senate Bill 277 in 2015, eliminating nonmedical exemptions to school immunization requirements. California elementary school personnel who worked with parents on meeting school immunization requirements were surveyed in 2022. Of the 122 survey respondents, half (50 %) were school principals, 11 % were registrars, 9 % were health clerks, and 7 % were nurses. Only one-quarter (26 %) believed their school had authority to deny medical exemptions. Almost half supported COVID-19 vaccine mandates for children in elementary (43 %), middle (44 %), and high (49 %) schools. Almost half (42 %) were concerned that children's immune systems could be weakened by too many shots, and nearly one-third thought immunizations do more harm than good (32 %). Among our sample of California schools, many personnel working with parents on meeting immunization requirements were not clinically trained, were unaware of their responsibility to deny invalid medical exemptions, and had vaccine concerns. Vaccine education for school personnel and further involvement of school nurses in the implementation and enforcement of school immunization requirements could have a positive impact on vaccine coverage and disease prevention., Competing Interests: Declaration of competing interest Matthew Dudley has received research support from Merck. Daniel Salmon has received research support from Merck and serves on advisory boards for Merck, Janssen, Sanofi and Moderna. Matthew Dudley and Daniel Salmon have received funding from the Vaccination Confidence Fund, which is jointly funded by Facebook and Merck. Alexander Zapf received support from Merck and Johnson and Johnson. Holly Schuh served as a (paid) health advisor to the University of Roehampton that provided guidance on recovery-building and future pandemic preparedness (including views on vaccines/vaccination) and understanding citizen engagement in the G7 in 2021–22 (during the presented study). Nicola Klein has received research support from Pfizer Sanofi Pasteur, Merck, GSK, Seqirus and CDC and is a member of the International Vaccine Institute Expert Panel on Hecolin. Saad Omer has received funding from the Bill and Melinda Gates Foundation, NIH, PATH, NIAID, UNICEF, and CDC and serves on the Gavi Vaccine Alliance Board and the Board of Trustees for the Sabin Vaccine Institute. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2025. Published by Elsevier Ltd.)
- Published
- 2025
- Full Text
- View/download PDF